...
首页> 外文期刊>Heterocycles: An International Journal for Reviews and Communications in Heterocyclic Chemistry >SYNTHESIS OF NOVEL PYRAZOLOPYRROLIZINONES AS PROSPECTIVE ANTICANCER AGENTS
【24h】

SYNTHESIS OF NOVEL PYRAZOLOPYRROLIZINONES AS PROSPECTIVE ANTICANCER AGENTS

机译:新型吡咯并吡咯啉酮类化合物作为预期的抗癌剂

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Herein we describe the access of novel pyrazolopyrrolizinones from commercial arylacetonitriles. The first step conducts to the corresponding aminoester which was first submitted to Clauson-Kaas procedure. Amidification and cyclisation afford then the first examples of the expected heterocycles. In order to improve the sequence and to obtain N-substituted isomers, 3-aryl-5-(pyrrolidin-1-ylcarbonyl)-4-(1H-pyrrol-1-yl)-1H-pyrazoles (5) were alkylated and conduct to two different TV-substituted pyrazoles. These novel products were separated by chromatography and clearly identified using different analytical techniques. Application of the cyclisation procedure conducts then to the two corresponding final title products.
机译:本文中,我们描述了从商业芳基乙腈中获得新型吡唑并吡咯烷酮的方法。第一步是处理相应的氨基酯,然后首先将其提交给Clauson-Kaas程序。然后酰胺化和环化提供了预期的杂环的第一个实例。为了改善序列并获得N-取代的异构体,将3-芳基-5-(吡咯烷-1-基羰基)-4-(1H-吡咯-1-基)-1H-吡唑(5)烷基化并进行两种不同的电视取代的吡唑通过色谱分离这些新颖的产物,并使用不同的分析技术对其进行清楚地鉴定。然后将环化程序应用于两个相应的最终标题产品。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号